Sponsored Content
FDA Alerts of Potential Missed Safety Notifications With Smartphone–Compatible Diabetes Devices
App notifications can be effected by various notification focuses, software updates, or connecting hardware, such as car audio or wireless earphones.
Episode 6: High Risk: Diabetes and COVID-19
In this episode of Over the Counter, 2 experts on diabetes management and care discuss the effect COVID-19 is having on individuals with diabetes and the ways that the health care system is responding.
FDA Approves Ranibizumab Injection for Diabetic Macular Edema
The therapy is now the first and only FDA-approved treatment that maintains vision with fewer treatments compared to standard-of-care injections.
Newer Diabetes Medications Associated With Lower Risk of MACE, Reductions in Hemoglobin A1c
Sodium-glucose cotransporter 2 inhibitors are more cardioprotective in older adults and glucagon-like peptide-1 receptor agonists for younger patients.
Defining Resilience in Adolescents with Type 1 Diabetes
There is no standard way to define resilience in adolescent patients with type 1 diabetes, though many studies see resilience as an ability or process.
Diabetes, Prediabetes Linked to Older Brain Age
Patients with diabetes and prediabetes have older brain ages than their chronological age compared with normoglycemic patients.
